ALLERGAN $16 MIL. ACQUISITION OF IOPTEX
This article was originally published in The Gray Sheet
Executive SummaryALLERGAN $16 MIL. ACQUISITION OF IOPTEX will increase the volume of the company's ophthalmic surgical products business by about a third, while significantly expanding Allergan's polymethylmethacrylate (PMMA) intraocular lens offerings. Under the agreement, announced Aug. 8, Allergan will purchase Irvine, California-based Ioptex for $16 mil. in cash and merge the firm into its surgical products business. Closure of the deal is contingent on "certain regulatory clearances."
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.